Literature DB >> 30446946

Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease.

Anna Bartoletti-Stella1, Patrizia Corrado2, Nicola Mometto2, Simone Baiardi2, Pascal F Durrenberger3, Thomas Arzberger4,5, Richard Reynolds6, Hans Kretzschmar5, Sabina Capellari7,8, Piero Parchi9,10.   

Abstract

Functional genomics applied to the study of RNA expression profiles identified several abnormal molecular processes in experimental prion disease. However, only a few similar studies have been carried out to date in a naturally occurring human prion disease. To better characterize the transcriptional cascades associated with sporadic Creutzfeldt-Jakob disease (sCJD), the most common human prion disease, we investigated the global gene expression profile in samples from the frontal cortex of 10 patients with sCJD and 10 non-neurological controls by microarray analysis. The comparison identified 333 highly differentially expressed genes (hDEGs) in sCJD. Functional enrichment Gene Ontology analysis revealed that hDEGs were mainly associated with synaptic transmission, including GABA (q value = 0.049) and glutamate (q value = 0.005) signaling, and the immune/inflammatory response. Furthermore, the analysis of cellular components performed on hDEGs showed a compromised regulation of vesicle-mediated transport with mainly up-regulated genes related to the endosome (q value = 0.01), lysosome (q value = 0.04), and extracellular exosome (q value < 0.01). A targeted analysis of the retromer core component VPS35 (vacuolar protein sorting-associated protein 35) showed a down-regulation of gene expression (p value= 0.006) and reduced brain protein levels (p value= 0.002). Taken together, these results confirm and expand previous microarray expression profile data in sCJD. Most significantly, they also demonstrate the involvement of the endosomal-lysosomal system. Since the latter is a common pathogenic pathway linking together diseases, such as Alzheimer's and Parkinson's, it might be the focus of future studies aimed to identify new therapeutic targets in neurodegenerative diseases.

Entities:  

Keywords:  Genome-wide expression; Human prion; Membrane trafficking; Retromer; Sporadic Creutzfeldt-Jakob disease; VPS35

Mesh:

Substances:

Year:  2018        PMID: 30446946     DOI: 10.1007/s12035-018-1421-1

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  105 in total

1.  A role for complement in transmissible spongiform encephalopathies.

Authors:  F Cardone; M Pocchiari
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Heightened intrathecal release of proinflammatory cytokines in Creutzfeldt-Jakob disease.

Authors:  M K Sharief; A Green; J P Dick; J Gawler; E J Thompson
Journal:  Neurology       Date:  1999-04-12       Impact factor: 9.910

4.  Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects.

Authors:  P Parchi; A Giese; S Capellari; P Brown; W Schulz-Schaeffer; O Windl; I Zerr; H Budka; N Kopp; P Piccardo; S Poser; A Rojiani; N Streichemberger; J Julien; C Vital; B Ghetti; P Gambetti; H Kretzschmar
Journal:  Ann Neurol       Date:  1999-08       Impact factor: 10.422

5.  Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie.

Authors:  N A Mabbott; M E Bruce; M Botto; M J Walport; M B Pepys
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

6.  Complement facilitates early prion pathogenesis.

Authors:  M A Klein; P S Kaeser; P Schwarz; H Weyd; I Xenarios; R M Zinkernagel; M C Carroll; J S Verbeek; M Botto; M J Walport; H Molina; U Kalinke; H Acha-Orbea; A Aguzzi
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

7.  Stimulation of PrP(C) retrograde transport toward the endoplasmic reticulum increases accumulation of PrP(Sc) in prion-infected cells.

Authors:  Florence Béranger; Alain Mangé; Bruno Goud; Sylvain Lehmann
Journal:  J Biol Chem       Date:  2002-08-05       Impact factor: 5.157

8.  GluR2/3, NMDAepsilon1 and GABAA receptors in Creutzfeldt-Jakob disease.

Authors:  I Ferrer; B Puig
Journal:  Acta Neuropathol       Date:  2003-06-27       Impact factor: 17.088

Review 9.  Synaptic pathology and cell death in the cerebellum in Creutzfeldt-Jakob disease.

Authors:  I Ferrer
Journal:  Cerebellum       Date:  2002-07       Impact factor: 3.847

10.  Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration.

Authors:  G R Mallucci; S Ratté; E A Asante; J Linehan; I Gowland; J G R Jefferys; J Collinge
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

View more
  9 in total

1.  Brain aging is faithfully modelled in organotypic brain slices and accelerated by prions.

Authors:  Yingjun Liu; Assunta Senatore; Silvia Sorce; Mario Nuvolone; Jingjing Guo; Zeynep H Gümüş; Adriano Aguzzi
Journal:  Commun Biol       Date:  2022-06-08

2.  Deciphering Copper Coordination in the Mammalian Prion Protein Amyloidogenic Domain.

Authors:  Giulia Salzano; Martha Brennich; Giordano Mancini; Thanh Hoa Tran; Giuseppe Legname; Paola D'Angelo; Gabriele Giachin
Journal:  Biophys J       Date:  2020-01-03       Impact factor: 4.033

3.  Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study.

Authors:  Emma Jones; Holger Hummerich; Emmanuelle Viré; James Uphill; Athanasios Dimitriadis; Helen Speedy; Tracy Campbell; Penny Norsworthy; Liam Quinn; Jerome Whitfield; Jacqueline Linehan; Zane Jaunmuktane; Sebastian Brandner; Parmjit Jat; Akin Nihat; Tze How Mok; Parvin Ahmed; Steven Collins; Christiane Stehmann; Shannon Sarros; Gabor G Kovacs; Michael D Geschwind; Aili Golubjatnikov; Karl Frontzek; Herbert Budka; Adriano Aguzzi; Hata Karamujić-Čomić; Sven J van der Lee; Carla A Ibrahim-Verbaas; Cornelia M van Duijn; Beata Sikorska; Ewa Golanska; Pawel P Liberski; Miguel Calero; Olga Calero; Pascual Sanchez-Juan; Antonio Salas; Federico Martinón-Torres; Elodie Bouaziz-Amar; Stéphane Haïk; Jean-Louis Laplanche; Jean-Phillipe Brandel; Phillipe Amouyel; Jean-Charles Lambert; Piero Parchi; Anna Bartoletti-Stella; Sabina Capellari; Anna Poleggi; Anna Ladogana; Maurizio Pocchiari; Serena Aneli; Giuseppe Matullo; Richard Knight; Saima Zafar; Inga Zerr; Stephanie Booth; Michael B Coulthart; Gerard H Jansen; Katie Glisic; Janis Blevins; Pierluigi Gambetti; Jiri Safar; Brian Appleby; John Collinge; Simon Mead
Journal:  Lancet Neurol       Date:  2020-09-16       Impact factor: 44.182

4.  Regional Differences in Neuroinflammation-Associated Gene Expression in the Brain of Sporadic Creutzfeldt-Jakob Disease Patients.

Authors:  Aušrinė Areškevičiūtė; Thomas Litman; Helle Broholm; Linea C Melchior; Pia R Nielsen; Alison Green; Jens O Eriksen; Colin Smith; Eva L Lund
Journal:  Int J Mol Sci       Date:  2020-12-25       Impact factor: 5.923

5.  Oral administration of repurposed drug targeting Cyp46A1 increases survival times of prion infected mice.

Authors:  Tahir Ali; Samia Hannaoui; Satish Nemani; Waqas Tahir; Irina Zemlyankina; Pearl Cherry; Su Yeon Shim; Valerie Sim; Hermann M Schaetzl; Sabine Gilch
Journal:  Acta Neuropathol Commun       Date:  2021-04-01       Impact factor: 7.801

6.  Identification of recurrent genetic patterns from targeted sequencing panels with advanced data science: a case-study on sporadic and genetic neurodegenerative diseases.

Authors:  G Castellani; S Capellari; M Tarozzi; A Bartoletti-Stella; D Dall'Olio; T Matteuzzi; S Baiardi; P Parchi
Journal:  BMC Med Genomics       Date:  2022-02-10       Impact factor: 3.063

7.  CSF Ubiquitin Levels Are Higher in Alzheimer's Disease than in Frontotemporal Dementia and Reflect the Molecular Subtype in Prion Disease.

Authors:  Samir Abu-Rumeileh; Patrick Oeckl; Simone Baiardi; Steffen Halbgebauer; Petra Steinacker; Sabina Capellari; Markus Otto; Piero Parchi
Journal:  Biomolecules       Date:  2020-03-25

8.  CSF SerpinA1 in Creutzfeldt-Jakob disease and frontotemporal lobar degeneration.

Authors:  Samir Abu-Rumeileh; Steffen Halbgebauer; Petra Steinacker; Sarah Anderl-Straub; Barbara Polischi; Albert C Ludolph; Sabina Capellari; Piero Parchi; Markus Otto
Journal:  Ann Clin Transl Neurol       Date:  2020-01-20       Impact factor: 4.511

Review 9.  The Role of Vesicle Trafficking Defects in the Pathogenesis of Prion and Prion-Like Disorders.

Authors:  Pearl Cherry; Sabine Gilch
Journal:  Int J Mol Sci       Date:  2020-09-23       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.